MOESM6 of Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36Â months
A Riccio(University of Palermo), Giorgio Canonica, Rossana Rossi(University of Parma), Pierluigi Mauri(Institute of Biomedical Technologies), L. Ferrari, Claudio Micheletto, Dario Di Silvestre, Roberto Dal Negro, Louise Benazzi(Institute of Genetic and Biomedical Research), Alessandra Chiappori(Ospedale Policlinico San Martino)
Cited by 0
Related Papers
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue
|Blood|2011|205
Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
|Immunology Letters|2014|101
Antioxidant Activity of All-trans-retinol in Homogeneous Solution and in Phosphatidylcholine Liposomes
|Archives of Biochemistry and Biophysics|1993|84